IMCC:NASDAQIM Cannabis Corp. Analysis

IM Cannabis Corp. (IMCC) is trading at $0.242, barely above its technical support of $0.219 and well below both the 20‑day SMA (~$0.254) and the 50‑day SMA (~$0.378), signaling a persistent bearish price trajectory. The RSI of 35 hints at modest oversold conditions, yet the MACD histogram is only marginally positive and the overall trend direction is classified as bearish, compounded by a decreasing volume trend that underscores weak market participation.
Fundamentally, the company posted $50.9 M in revenue, but that represents a 30% decline year‑over‑year, with gross margins at just 15% and operating margins deep in the red at –19%. Net earnings are negative, EPS is –$2.28, and the balance sheet shows $14.96 M of debt against essentially zero equity, resulting in a negative book value per share. Free cash flow is strongly negative, and there is no dividend history. High 30‑day volatility (≈90%) and a low beta (~0.19) indicate price swings that are largely company‑specific, while the “Extreme Greed” reading on the Fear & Greed Index reflects speculative sentiment rather than intrinsic value.